Results 121 to 130 of about 9,247 (168)

Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myeloma. [PDF]

Front Oncol
Bertuglia G, Di Nicola A, Gay F, Larocca A, Bruno B, D'Agostino M.   +5 more
europepmc   +1 more source

Case Report: Autologous stem cell transplantation in a patient diagnosed with AL amyloidosis in Kazakhstan. [PDF]

Front Oncol
Kolesnikova O, Kemaykin V, Burkitbayev Z, Karabekov A, Kolesnev A, Ainabay A, Ruzal V, Yusupova M, Shokubaeva F, Tursyn A, Kuanysh Z.   +10 more
europepmc   +1 more source

Patient With MGRS/PGNMID Without Detection of a Peripheral Clone: Case Report and Literature Review. [PDF]

Case Rep Hematol
Larrazábal A, Ávila-Rodriguez A, Sánchez M.   +2 more
europepmc   +1 more source

Impact of 1q vulnerabilities in patients treated with anti-CD38 monoclonal antibodies. [PDF]

Front Oncol
Sánchez-Tabernero M, Zamanillo I, Sánchez-Pina JM, Alonso-Fernandez R, López-Muñoz N, Corona M, Fernández-Guijarro M, Cedena MT, Cortijo S, Calbacho M, Martinez-Lopez J.   +10 more
europepmc   +1 more source

Brazilian consensus recommendations on the diagnosis and treatment of light chain amyloidosis. [PDF]

Hematol Transfus Cell Ther
Garibaldi PMM, Souto Filho JTD, de Magalhães Filho RJP, Szor RS, Miguel CE, Crusoe E, Bueno CT, Queiroz T, Hungria V.   +8 more
europepmc   +1 more source

Case Report: Dual impact of daratumumab in early T-cell precursor acute lymphoblastic leukemia -- consolidation therapy achieves remission and eliminates donor-specific HLA antibodies. [PDF]

Front Immunol
Wong KL, Tuy T, Quek J, Linn YC.
europepmc   +1 more source

Exercise-mobilized lymphocytes enhance antibody-based immunotherapy in multiple myeloma through CD16⁺ NK cell-mediated cytotoxicity. [PDF]

J Transl Med
Chou L, Valenzuela AM, McDougal LM, Baker FL, Katsanis E, Simpson RJ.   +5 more
europepmc   +1 more source

Daratumumab induced lichenoid drug eruption. [PDF]

JAAD Case Rep
Perz C, Wissman T, Montebello A.
europepmc   +1 more source

Daratumumab plus bortezomib and dexamethasone (Dara-VD) in newly diagnosed Mayo 2004 stage IIIA and IIIB light-chain amyloidosis: Long-term follow-up results from a prospective phase 2 study. [PDF]

Br J Haematol
Xue-Min G, Chengyang X, Ya-Juan G, Ai G, Yi X, Long C, Kai-Ni S, Jian L.   +7 more
europepmc   +1 more source

Treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with multiple myeloma: longer follow-up of the real-world MMY4032 study. [PDF]

Ann Hematol
Yang W, Wang L, Wang Y, Niu T, Fu R, Zhong Y, Qian W, Ding K, Sun K, Liu H, Fang B, Liu H, Li Y, Yang Y, Zhuo J, Chen X, Xun B, Lu J.   +17 more
europepmc   +1 more source